These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16800100)

  • 21. Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and Zambia.
    Ellis JC; L'homme RF; Ewings FM; Mulenga V; Bell F; Chileshe R; Molyneux E; Abernethy J; van Oosterhout JJ; Chintu C; Walker AS; Gibb DM; Burger DM
    Antivir Ther; 2007; 12(2):253-60. PubMed ID: 17503667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized pahse I bioequivalence clinincal trial of a paediatric fixed-dose combination antiretroviral reconstitutable suspension in healthy adult volunteers.
    Esseku F; Joshi A; Oyegbile Y; Edowhorhu G; Gbadero D; Adeyeye M
    Antivir Ther; 2013; 18(2):205-12. PubMed ID: 23653910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian children.
    Corbett AH; Hosseinipour MC; Nyirenda J; Kanyama C; Rezk NL; Mkupani P; Sichali D; Tien H; Kashuba AD; Mwansambo C; Weigel R; Kazembe P
    Antivir Ther; 2010; 15(1):83-90. PubMed ID: 20167994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioequivalence study of two nevirapine tablet formulations in human-immunodeficiency-virus-infected patients.
    Tarinas A; Tápanes RD; González D; Ferrer G; Abreu D; Pérez J
    Farm Hosp; 2007; 31(3):165-8. PubMed ID: 17941755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine.
    Chokephaibulkit K; Plipat N; Cressey TR; Frederix K; Phongsamart W; Capparelli E; Kolladarungkri T; Vanprapar N
    AIDS; 2005 Sep; 19(14):1495-9. PubMed ID: 16135903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets.
    Fillekes Q; Mulenga V; Kabamba D; Kankasa C; Thomason MJ; Cook A; Ferrier A; Chintu C; Walker AS; Gibb DM; Burger DM
    AIDS; 2012 Sep; 26(14):1795-800. PubMed ID: 22739394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioequivalence of abacavir generic and innovator formulations under fasting and fed conditions.
    Marier JF; Borges M; Plante G; Dimarco M; Morelli G; Tippabhotla SK; Vijan T; Singla AK; Garg M; Monif T
    Int J Clin Pharmacol Ther; 2006 Jun; 44(6):284-91. PubMed ID: 16800101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of lamivudine in human plasma by HPLC and its use in bioequivalence studies.
    Kano EK; dos Reis Serra CH; Koono EE; Andrade SS; Porta V
    Int J Pharm; 2005 Jun; 297(1-2):73-9. PubMed ID: 15907596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of two generic fixed-dose combinations for HIV-infected children (Pedimune Baby & Pedimune Junior) are similar to the branded products in healthy adults.
    L'homme RF; Dijkema T; Warris A; van der Ven AJ; Gibb DM; Burger DM
    J Antimicrob Chemother; 2007 Jan; 59(1):92-6. PubMed ID: 17071953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of nevirapine: once-daily versus twice-daily dosing in the 2NN study.
    Kappelhoff BS; Huitema AD; van Leth F; Robinson PA; MacGregor TR; Lange JM; Beijnen JH;
    HIV Clin Trials; 2005; 6(5):254-61. PubMed ID: 16306032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous determination of lamivudine, stavudine and nevirapine in human plasma by LC-MS/MS and its application to pharmacokinetic study in clinic.
    Li Z; Ding C; Ge Q; Zhou Z; Zhi X; Liu X
    Biomed Chromatogr; 2010 Sep; 24(9):926-34. PubMed ID: 20058328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-dose pharmacokinetic properties, bioavailability, and tolerability of two lamivudine 100-mg tablet formulations: a randomized crossover study in healthy Chinese male subjects.
    Li X; Liu B; Sun Y; Chen H; Chen H; Zhang H; Zhang Q; Ding Y
    Clin Ther; 2013 Oct; 35(10):1546-56. PubMed ID: 24011635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic profiling and bioequivalence evaluation of 2 lamivudine tablet formulations after single oral administration in healthy human Indian volunteers.
    Narang VS; Lulla A; Malhotra G; Purandare S
    J Acquir Immune Defic Syndr; 2005 Apr; 38(5):566-9. PubMed ID: 15793367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioequivalence and pharmacokinetics of two zidovudine formulations in healthy Brazilian volunteers: an open-label, randomized, single-dose, two-way crossover study.
    Dos Reis Serra CH; Mori Koono EE; Kano EK; Schramm SG; Armando YP; Porta V
    Clin Ther; 2008 May; 30(5):902-8. PubMed ID: 18555936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioequivalence of two lamivudine tablet formulations.
    Santos-Magalhães NS; Pontes A; Cavalcante RM; Costa RM; Rangel FA; Guimarães MI; de Carvalho JN; de Souza SD; de Oliveira HM; Esteves IL; Ramalho MS; Vieira SL; Alves AJ
    Arzneimittelforschung; 2001; 51(4):310-4. PubMed ID: 11367872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma nevirapine levels and 24-week efficacy of a fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) among Thai HIV-infected patients.
    Manosuthi W; Kiertiburanakul S; Chaovavanich A; Sungkanuparph S
    J Med Assoc Thai; 2007 Feb; 90(2):244-50. PubMed ID: 17375627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioequivalence of dispersed stavudine: opened versus closed capsule dosing.
    Innes S; Norman J; Smith P; Smuts M; Capparelli E; Rosenkranz B; Cotton M
    Antivir Ther; 2011; 16(7):1131-4. PubMed ID: 22024529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steady-state nevirapine, lamivudine and stavudine levels in Malawian HIV-infected children on antiretroviral therapy using split Triomune 30 tablets.
    Poerksen G; Pollock L; Moons P; Chesshyre E; Burger D; Khoo S; Molyneux E
    Antivir Ther; 2010; 15(3):343-50. PubMed ID: 20516554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nevirapine and efavirenz pharmacokinetics and covariate analysis in the 2NN study.
    Kappelhoff BS; van Leth F; MacGregor TR; Lange J; Beijnen JH; Huitema AD;
    Antivir Ther; 2005; 10(1):145-55. PubMed ID: 15751772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic profiling and bioequivalence assessment of two marketed brands of nevirapine tablets in healthy Indian volunteers.
    Narang VS; Lulla A; Malhotra G; Purandare S
    Arzneimittelforschung; 2005; 55(10):598-603. PubMed ID: 16294506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.